Back to Results
First PageMeta Content
Medicinal chemistry / Galapagos NV / Onno van de Stolpe / Pharmaceutical industry / High-throughput screening / Compound management / ADME / Euronext / Galápagos Islands / Pharmaceutical sciences / Pharmacology / Drug discovery


Microsoft Word - BFDPI-DNS_PRfinaldraft.doc
Add to Reading List

Document Date: 2012-08-22 19:32:09

Open Document

File Size: 122,68 KB

Share Result on Facebook

City

San Francisco / Amsterdam / Mechelen / San Diego / Brussels / /

Company

Dart Neuroscience LLC / BioFocus DPI / Discovery Platform Technology / Cold Spring Harbor Laboratory / Galapagos NV / Helicon Therapeutics Inc. / /

Country

Belgium / United States / /

Currency

USD / EUR / /

/

Event

Business Partnership / /

IndustryTerm

compound management / target-to-drug discovery products / /

MedicalCondition

brain disorders / joint diseases / bone metastasis / cognitive dysfunction / /

OperatingSystem

Spring / /

Organization

Dart NeuroGenomics Alliance / /

Person

Tim Tully / Onno van de Stolpe / /

/

Position

Chief Scientific Officer / CEO / Chief Scientific Officer of DNS / /

Technology

drug discovery / high-throughput screening / drug screening / /

URL

www.dartneuroscience.com / www.glpg.com / www.biofocusdpi.com / /

SocialTag